CD8A and myeloid sarcoma: For example, a recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine study revealed that vaccine-specific responses of CD4+ T cells were mildly attenuated, while vaccine-specific responses of CD8+ T cells were enhanced in patients with MS treated with aCD20 (61).